Hillsdale Investment Management Inc. Novo Cure LTD Transaction History

Hillsdale Investment Management Inc.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2020 Nov 13, 2020	SELL	$58.05 - $111.31 $597,915 - $1.15 Million	-10,300 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$68.3 - $93.8 $703,490 - $966,140	10,300 New	10,300 $868,000

278

73.2M

1.43M

832K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.76B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Hillsdale Investment Management Inc., based on Form 13F filings with the SEC.

Stay updated on Hillsdale Investment Management Inc. with notifications on news.